{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T14:18:54Z","timestamp":1783693134233,"version":"3.55.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:00:00Z","timestamp":1777334400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:00:00Z","timestamp":1777334400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ther Innov Regul Sci"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s43441-026-00978-0","type":"journal-article","created":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T13:24:35Z","timestamp":1777382675000},"page":"1144-1154","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparative Assessment of the Pharmaceutical Quality of Amoxicillin Capsules Marketed in Authorized and an Unregulated Point of Sale in Mexican Market"],"prefix":"10.1007","volume":"60","author":[{"given":"Gael","family":"Marmolejo-Bernal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leny","family":"Mej\u00eda-Amaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Ben\u00edtez-Escamilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberta Lourdes","family":"Castillo-Granada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leticia","family":"Cruz-Antonio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,28]]},"reference":[{"issue":"1","key":"978_CR1","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41572-022-00387-1","volume":"8","author":"OZ Pyzik","year":"2025","unstructured":"Pyzik OZ, Abubakar I. Fighting the fakes: tackling substandard and falsified medicines. Nat Rev Dis Primers. 2025;8(1):55.","journal-title":"Nat Rev Dis Primers"},{"key":"978_CR2","unstructured":"World Health Organization. The WHO Member State mechanism on substandard and falsified medical products: how WHO Member States work together to increase access to safe, effective and quality medicines, vaccines and other medical products, update 2022.World Health Organization. License: CC BY-NC-SA 3.0 IGO. https:\/\/iris.who.int\/handle\/10665\/365562."},{"key":"978_CR3","unstructured":"C\u00e1mara de Diputados. 5452 - Hasta 90 por ciento de las medicinas adquiridas por Internet podr\u00edan ser irregulares: Secretar\u00eda de Salud \/ 12 \/ Mayo \/ 2018 \/ Boletines \/ Comunicaci\u00f3n \/ Inicio - Camara de Diputados [Internet]. Diputados.gob.mx. 2018. Available: http:\/\/www5.diputados.gob.mx\/index.php\/esl\/Comunicacion\/Boletines\/2018\/Mayo\/12\/5452-Hasta-90-por-ciento-de-las-medicinas-adquiridas-por-Internet-podrian-ser-irregulares-Secretaria-de-Salud"},{"key":"978_CR4","unstructured":"WHO. Member State Mechanism for Substandard\/Falsified Medical Products (Mech) Working Group (H) on Informal Markets, 2024. https:\/\/www.fda.gov\/media\/185066\/download?attachment"},{"key":"978_CR5","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2020-002393","volume":"5","author":"D McManus","year":"2020","unstructured":"McManus D, Naughton BD. A systematic review of substandard, falsified, unlicensed and unregistered medicine sampling studies: a focus on context, prevalence, and quality. BMJ Glob Health. 2020;5:e002393.","journal-title":"BMJ Glob Health"},{"issue":"9\/10","key":"978_CR6","first-page":"37","volume":"20","author":"S Pe\u00f1a","year":"2000","unstructured":"Pe\u00f1a S. Regulating informal markets: informal commerce in Mexico City. Int J Soc Sci Perspect. 2000;20(9\/10):37\u201367.","journal-title":"Int J Soc Sci Perspect"},{"issue":"2","key":"978_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmicom.2024.105035","volume":"1","author":"M Sharland","year":"2024","unstructured":"Sharland M, Cook A, Pouwels KB, et al. Universal access to key essential antibiotics\u2014Recent amoxicillin global shortages mask a wider policy failure. CMI Commun. 2024;1(2):105035.","journal-title":"CMI Commun"},{"issue":"8","key":"978_CR8","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2022-008587","volume":"7","author":"GA Zabala","year":"2022","unstructured":"Zabala GA, Bellingham K, Vidhamaly V, et al. Substandard and falsified antibiotics: neglected drivers of antimicrobial resistance? BMJ Glob Health. 2022;7(8):e008587.","journal-title":"BMJ Glob Health"},{"key":"978_CR9","unstructured":"World. Alerta n.\u00b0 2\/2025 sobre productos m\u00e9dicos [Internet]. Who.int. World Health Organization: WHO; 2025. Available in: https:\/\/www.who.int\/es\/news\/item\/23-04-2025-medical-product-alert-n-2-2025--falsified-healmoxy-(amoxicillin)-capsules-500mg"},{"issue":"8","key":"978_CR10","doi-asserted-by":"publisher","DOI":"10.2196\/29309","volume":"7","author":"E Pisani","year":"2021","unstructured":"Pisani E, Hasnida A, Rahmi M, et al. Substandard and falsified medicines: proposed methods for case finding and sentinel surveillance. JMIR Public Health Surveill. 2021;7(8):e29309.","journal-title":"JMIR Public Health Surveill"},{"key":"978_CR11","doi-asserted-by":"publisher","DOI":"10.26633\/RPSP.2020.125","volume":"44","author":"R Rojas-Cort\u00e9s","year":"2020","unstructured":"Rojas-Cort\u00e9s R. Substandard, falsified and unregistered medicines in Latin America. Rev Panam Salud Publica. 2020;44:e125.","journal-title":"Rev Panam Salud Publica"},{"key":"978_CR12","unstructured":"United States. Department of Health and Human Services, issuing body. United States. Food and Drug Administration, issuing body. Center for Drug Evaluation and Research (U.S.). Size, Shape, and Other Physical Attributes of Generic Tablets and Capsules Guidance for Industry. Silver Spring, MD: Center for Drug Evaluation and Research, October 2022. NLM Unique ID: 9918504289006676"},{"key":"978_CR13","volume-title":"Control of physical properties in pharmaceutical forms","author":"BM Colombo","year":"1976","unstructured":"Colombo BM. Control of physical properties in pharmaceutical forms. Italy: Organizzazione Editoriale Medico-Farmaceutica; 1976."},{"key":"978_CR14","unstructured":"Farmacopea de los Estados Unidos Mexicanos. 13 edici\u00f3n. M\u00e9xico, Secretar\u00eda de Salud, Comisi\u00f3n Permanente de la Farmacopea de los Estados Unidos Mexicanos; 2021."},{"key":"978_CR15","unstructured":"NOM-177-SSA1\u20132013, Que establece las pruebas y procedimientos para demostrar que un medicamento es intercambiable. Requisitos a que deben sujetarse los Terceros Autorizados que realicen las pruebas de intercambiabilidad. Requisitos para realizar los estudios de biocomparabilidad. Requisitos a que deben sujetarse los Terceros Autorizados, Centros de Investigaci\u00f3n o Instituciones Hospitalarias que realicen las pruebas de biocomparabilidad. 2013."},{"issue":"6","key":"978_CR16","first-page":"64","volume":"20","author":"JW Moore","year":"1996","unstructured":"Moore JW, Flanner HH. Mathematical comparison of dissolution profiles. Pharm Technol. 1996;20(6):64\u201374.","journal-title":"Pharm Technol"},{"issue":"2","key":"978_CR17","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/S0928-0987(01)00095-1","volume":"13","author":"P Costa","year":"2001","unstructured":"Costa P, Lobo JMS. Modeling and comparison of dissolution profiles. Eur J Pharm Sci. 2001;13(2):123\u201333.","journal-title":"Eur J Pharm Sci"},{"issue":"2","key":"978_CR18","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1128\/CMR.00072-14","volume":"28","author":"T Kelesidis","year":"2015","unstructured":"Kelesidis T, Falagas ME. Substandard\/counterfeit antimicrobial drugs. Clin Microbiol Rev. 2015;28(2):443\u201364.","journal-title":"Clin Microbiol Rev"},{"issue":"10","key":"978_CR19","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1080\/03639040500306245","volume":"31","author":"KL Karlage","year":"2005","unstructured":"Karlage KL, Myrdal PB. Comparison of three pharmaceutical products obtained from Mexico and the United States: a case study. Drug Dev Ind Pharm. 2005;31(10):993\u20131000.","journal-title":"Drug Dev Ind Pharm"},{"issue":"3","key":"978_CR20","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1208\/s12248-012-9350-9","volume":"14","author":"R L\u00f6benberg","year":"2012","unstructured":"L\u00f6benberg R, Chacra NB, Stippler ES, et al. Toward global standards for comparator pharmaceutical products: case studies of amoxicillin, metronidazole, and zidovudine in the Americas. AAPS J. 2012;14(3):462\u201372.","journal-title":"AAPS J"},{"key":"978_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics9070407","volume":"9","author":"T Jean-Baptiste","year":"2020","unstructured":"Jean-Baptiste T, Carpenter JF, Dahl K, et al. Substandard quality of the antimicrobials sold in the street markets in Haiti. Antibiotics. 2020;9:407.","journal-title":"Antibiotics"},{"key":"978_CR22","unstructured":"COFEPRIS. Consulta de Registros Sanitarios. Portal de COFEPRIS. 2025. https:\/\/tramiteselectronicos02.cofepris.gob.mx\/BuscadorPublicoRegistrosSanitarios\/BusquedaRegistroSanitario.aspx"},{"issue":"2","key":"978_CR23","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1111\/bcp.12298","volume":"78","author":"A Johnston","year":"2014","unstructured":"Johnston A, Holt DW. Substandard drugs: a potential crisis for public health. Br J Clin Pharmacol. 2014;78(2):218\u201343.","journal-title":"Br J Clin Pharmacol"},{"key":"978_CR24","first-page":"11","volume":"5","author":"BD Glass","year":"2014","unstructured":"Glass BD. Counterfeit drugs and medical devices in developing countries. Res Rep Trop Med. 2014;5:11\u201322.","journal-title":"Res Rep Trop Med"},{"issue":"4","key":"978_CR25","doi-asserted-by":"publisher","first-page":"656","DOI":"10.34172\/apb.2020.079","volume":"10","author":"F Molavi","year":"2020","unstructured":"Molavi F, Hamishehkar H, Nokhodchi A. Impact of tablet shape on drug dissolution rate through immediate released tablets. Adv Pharm Bull. 2020;10(4):656\u201361.","journal-title":"Adv Pharm Bull"},{"key":"978_CR26","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/2050-6511-14-33","volume":"14","author":"MH Khan","year":"2013","unstructured":"Khan MH, Hatanaka K, Sovannarith T, et al. Effects of packaging and storage conditions on the quality of amoxicillin-clavulanic acid\u2014An analysis of Cambodian samples. BMC Pharmacol Toxicol. 2013;14:33.","journal-title":"BMC Pharmacol Toxicol"},{"issue":"11","key":"978_CR27","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1248\/cpb.49.1412","volume":"49","author":"N Katori","year":"2001","unstructured":"Katori N, Aoyagi N, Kojima S. The study of the applicability of content uniformity and weight variation test\u2014The state of commercial tablets and capsules in Japan. Chem Pharm Bull (Tokio). 2001;49(11):1412\u20139.","journal-title":"Chem Pharm Bull (Tokio)"},{"issue":"2","key":"978_CR28","first-page":"193","volume":"8","author":"E Vrani\u0107","year":"2008","unstructured":"Vrani\u0107 E, Uzunovi\u0107 A. Study of the applicability of content uniformity and dissolution variation test on ropinirole hydrochloride tablets. Bosn J Basic Med Sci. 2008;8(2):193\u2013200.","journal-title":"Bosn J Basic Med Sci"},{"key":"978_CR29","doi-asserted-by":"publisher","DOI":"10.1002\/0470011149","volume-title":"Infrared spectroscopy: fundamentals and applications","author":"BH Stuart","year":"2004","unstructured":"Stuart BH. Infrared spectroscopy: fundamentals and applications. Chichester, England: John Wiley & Sons; 2004."},{"issue":"1","key":"978_CR30","doi-asserted-by":"publisher","first-page":"65","DOI":"10.2116\/analsci.33.65","volume":"33","author":"Y Hattori","year":"2017","unstructured":"Hattori Y, Otsuka M. ATR\/FT-IR and NIR auto-correlation spectroscopic analysis of powder blending uniformity of low-content Magnesium Stearate and Potato Starch. Anal Sci. 2017;33(1):65\u20138.","journal-title":"Anal Sci"},{"issue":"1","key":"978_CR31","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/1467-9884.00176","volume":"48","author":"A Dunne","year":"1999","unstructured":"Dunne A, Devane J, O\u00b4Hara T. The relationship between in vitro drug dissolution and in vivo absorption. Statistician. 1999;48(1):125\u201333.","journal-title":"Statistician"}],"container-title":["Therapeutic Innovation & Regulatory Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43441-026-00978-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s43441-026-00978-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43441-026-00978-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T13:49:50Z","timestamp":1783691390000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s43441-026-00978-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,28]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["978"],"URL":"https:\/\/doi.org\/10.1007\/s43441-026-00978-0","relation":{},"ISSN":["2168-4790","2168-4804"],"issn-type":[{"value":"2168-4790","type":"print"},{"value":"2168-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,28]]},"assertion":[{"value":"6 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}